ICON
The Global Clinical Project Manager at ICON will be embedded within the AstraZeneca FSP program, supporting early-phase haematology clinical development. The role sits within ICON Strategic Solutions and partners closely with AstraZeneca’s global clinical operations to deliver integrated clinical study programs. This position focuses on study leadership within a CRO environment working across internal and external stakeholders.
Headquarters
Austin, Texas, United States
Company Size
201-500 employees
Founded
2017
ICON develops advanced construction technologies—large‑scale 3D printing robotics, proprietary software, and engineered materials—to accelerate and democratize building. The company supplies hardware, software and integrated construction services for homes and infrastructure, partnering with developers, governments and humanitarian organizations to deliver faster, lower‑cost, resilient structures. By automating construction and optimizing materials, ICON reduces labor, waste and build time while enabling new designs and scalable community solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON.
ICON didn’t post a salary, so this is our estimate from similar listings.
ICON launches Titan printer rollout for construction companies
2 days ago
Global Study Manager - Haematology
lifelancer
Clinical Trial Lead (m/w/d)
IQVIA
Clinical Project Manager II
Perceptive
Global Study Manager - Haematology
American Association of Physicists in Medicine
Clinical Trials Manager (12-Month Contract)
Zymeworks
Senior Director of Clinical Operations
Flagship Pioneering, Inc.